COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,225 Articles (22,733 medRxiv, 8,492 bioRxiv)

Most recent first Previous |  Page 2158: Articles 21571-21580  | Next

The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir
Zhao, Y., Sun, J., Li, Y., Li, Z., Xie, Y., Feng, R., Zhao, J., Hu, Y.
10.1101/2020.10.15.325050 — Posted: 2020-10-15
Multiplexed proteomics and imaging of resolving and lethal SARS-CoV-2 infection in the lung
Kalocsay, M., Maliga, Z., Nirmal, A. J., Eisert, R. J., Bradshaw, G. A., Solomon, I. H., Chen, Y.-A., Pelletier, R. J., Jacobson, C. A., Mintseris, J., Padera, R. F., Martinot, A. J., Barouch, D. H., Santagata, S., Sorger, P.
10.1101/2020.10.14.339952 — Posted: 2020-10-15
Inhibition of SARS-CoV-2 viral entry in vitro upon blocking N- and O-glycan elaboration
Yang, Q., Hughes, T. A., Kelkar, A., Yu, X., Cheng, K., Park, S. J., Huang, W.-C., Lovell, J. F., Neelamegham, S.
10.1101/2020.10.15.339838 — Posted: 2020-10-15
A high throughput RNA displacement assay for screening SARS-CoV-2 nsp10-nsp16 complex towards developing therapeutics for COVID-19
Perveen, S., Khalili Yazdi, A., Devkota, K., Li, F., Ghiabi, P., Hajian, T., Loppnau, P., Bolotokova, A., Vedadi, M.
10.1101/2020.10.14.340034 — Posted: 2020-10-15
Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results
WHO Solidarity Trial Consortium, , Pan, H., Peto, R., Abdool Karim, Q., Alejandria, M., Henao Restrepo, A. M., Hernandez Garcia, C., Kieny, M. P., Malekzadeh, R., Murthy, S., Preziosi, M.-P., Reddy, S., Roses, M., Sathiyamoorthy, V., Rottingen, J.-A., Swaminathan, S.
10.1101/2020.10.15.20209817 — Posted: 2020-10-15 Discussion: Onsite | Offsite
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols
Chen, P. Z., Bobrovitz, N., Premji, Z., Koopmans, M., Fisman, D. N., Gu, F. X.
10.1101/2020.10.13.20212233 — Posted: 2020-10-15
Physical Activity Decreases the Prevalence of COVID-19-associated Hospitalization: Brazil EXTRA Study
Souza, F. R., Motta-Santos, D., Soares, D. d. S., Lima, J. B., Cardozo, G. G., Guimaraes, L. S. P., Negrao, C. E., dos Santos, M. R.
10.1101/2020.10.14.20212704 — Posted: 2020-10-15
Development of a deep learning classifier to accurately distinguish COVID-19 from look-a-like pathology on lung ultrasound
Arntfield, R., VanBerlo, B., Alaifan, T., Phelps, N., White, M., Chaudhary, R., Ho, J., Wu, D.
10.1101/2020.10.13.20212258 — Posted: 2020-10-15
Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity
Dai, C. L., Kornilov, S. A., Roper, R. T., Cohen-Cline, H., Jade, K., Smith, B., Heath, J. R., Diaz, G., Goldman, J. D., Hadlock, J. J., Magis, A. T.
10.1101/2020.10.14.20212803 — Posted: 2020-10-15 Discussion: Offsite
Sociodemographic correlates of access to sanitary pads among college students in Lucknow during COVID 19 lockdown
Garg, S., Alvi, R., Gupta, S., Ahmad, A.
10.1101/2020.10.14.20210815 — Posted: 2020-10-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).